154 related articles for article (PubMed ID: 15334642)
1. Management of hepatocellular carcinoma in renal transplant recipients.
Chok KS; Lam CM; Li FK; Ng KK; Poon RT; Lo CM; Fan ST
J Surg Oncol; 2004 Sep; 87(3):139-42. PubMed ID: 15334642
[TBL] [Abstract][Full Text] [Related]
2. Hepatic resection for bilobar hepatocellular carcinoma: is it justified?
Liu CL; Fan ST; Lo CM; Ng IO; Poon RT; Wong J
Arch Surg; 2003 Jan; 138(1):100-4. PubMed ID: 12511161
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in renal transplant patients.
Ridruejo E; Mandó OG; Dávalos M; Díaz C; Vilches A
Transplant Proc; 2005 Jun; 37(5):2086-8. PubMed ID: 15964346
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in renal transplant recipients.
Chuang CH; Chien YS; Cheng YT; Chen YT; Hu TH; Hsieh H
Transplant Proc; 2008 Sep; 40(7):2392-4. PubMed ID: 18790244
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
[TBL] [Abstract][Full Text] [Related]
6. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
Castroagudín JF; Molina E; Bustamante M; Tomé S; Otero E; Martínez J; Segade FR; Conde R; Varo E
Transplant Proc; 2008 Nov; 40(9):2975-7. PubMed ID: 19010164
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatocellular carcinoma with liver transplantation: a single-center experience from Brazil.
Teixeira AC; Mente ED; Castro-e-Silva O; Sankarankutty AK; Cantão CA; Souza FF; Abud D; Muglia V; Elias-Junior J; Martinelli AL
Transplant Proc; 2010 Mar; 42(2):502-4. PubMed ID: 20304177
[TBL] [Abstract][Full Text] [Related]
8. [Transarterial oil chemoembolization for hepatocellular carcinoma, in 100 cases].
Levy I; Verstandig A; Sasson T; Wolf D; Krichon I; Libson E; Levensart P; Papo O; Yurim O; Id A; Shouval D
Harefuah; 2000 Jan; 138(2):89-93, 174. PubMed ID: 10883065
[TBL] [Abstract][Full Text] [Related]
9. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
Wen J; Shen WL; Yang SH
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
[TBL] [Abstract][Full Text] [Related]
11. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
Lao OB; Weissman J; Perkins JD
Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
[TBL] [Abstract][Full Text] [Related]
12. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
13. The outcome of surgical resection versus assignment to the liver transplant waiting list for hepatocellular carcinoma.
Pierie JP; Muzikansky A; Tanabe KK; Ott MJ
Ann Surg Oncol; 2005 Jul; 12(7):552-60. PubMed ID: 15889217
[TBL] [Abstract][Full Text] [Related]
14. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India.
Paul SB; Chalamalasetty SB; Vishnubhatla S; Madan K; Gamanagatti SR; Batra Y; Gupta SD; Panda SK; Acharya SK
Oncology; 2009; 77(3-4):162-71. PubMed ID: 19641335
[TBL] [Abstract][Full Text] [Related]
15. Ruptured hepatocellular carcinoma as a complication of transarterial oily chemoembolization.
Liu CL; Ngan H; Lo CM; Fan ST
Br J Surg; 1998 Apr; 85(4):512-4. PubMed ID: 9607536
[TBL] [Abstract][Full Text] [Related]
16. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
[TBL] [Abstract][Full Text] [Related]
17. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study.
McMahon BJ; Bulkow L; Harpster A; Snowball M; Lanier A; Sacco F; Dunaway E; Williams J
Hepatology; 2000 Oct; 32(4 Pt 1):842-6. PubMed ID: 11003632
[TBL] [Abstract][Full Text] [Related]
18. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous rupture of hepatocellular carcinoma: a Western experience.
Battula N; Madanur M; Priest O; Srinivasan P; O'Grady J; Heneghan MA; Bowles M; Muiesan P; Heaton N; Rela M
Am J Surg; 2009 Feb; 197(2):164-7. PubMed ID: 18926518
[TBL] [Abstract][Full Text] [Related]
20. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG
J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]